Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 5;128(13):1748-54.
doi: 10.4103/0366-6999.159348.

Mitochondrial DNA Haplogroups and the Risk of Sporadic Parkinson's Disease in Han Chinese

Affiliations

Mitochondrial DNA Haplogroups and the Risk of Sporadic Parkinson's Disease in Han Chinese

Ya-Fang Chen et al. Chin Med J (Engl). .

Abstract

Background: Mitochondrial dysfunction is linked to the pathogenesis of Parkinson's disease (PD). However, the precise role of mitochondrial DNA (mtDNA) variations is obscure. On the other hand, mtDNA haplogroups have been inconsistently reported to modify the risk of PD among different population. Here, we try to explore the relationship between mtDNA haplogroups and sporadic PD in a Han Chinese population.

Methods: Nine single-nucleotide polymorphisms, which define the major Asian mtDNA haplogroups (A, B, C, D, F, G), were detected via polymerase chain reaction-restriction fragment length polymorphism or denaturing polyacrylamide gel electrophoresis in 279 sporadic PD patients and 510 matched controls of Han population.

Results: Overall, the distribution of mtDNA haplogroups did not show any significant differences between patients and controls. However, after stratification by age at onset, the frequency of haplogroup B was significantly lower in patients with early-onset PD (EOPD) compared to the controls (odds ratio [OR] =0.225, 95% confidence interval [CI]: 0.082-0.619, P = 0.004), while other haplogroups did not show significant differences. After stratification by age at examination, among subjects younger than 50 years of age: Haplogroup B also showed a lower frequency in PD cases (OR = 0.146, 95% CI: 0.030-0.715, P = 0.018) while haplogroup D presented a higher risk of PD (OR = 3.579, 95% CI: 1.112-11.523, P = 0.033), other haplogroups also did not show significant differences in the group.

Conclusions: Our study indicates that haplogroup B might confer a lower risk for EOPD and people younger than 50 years in Han Chinese, while haplogroup D probably lead a higher risk of PD in people younger than 50 years of age. In brief, particular Asian mtDNA haplogroups likely play a role in the pathogenesis of PD among Han Chinese.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Classification of major Asian mitochondrial DNA haplogoups.
Figure 2
Figure 2
Polymerase chain reaction-restriction fragment length polymorphism products of mitochondrial DNA single nucleotide polymorphism A10398G and C10400T analyzed with agarose gel electrophoresis. Lane M: D2000 marker; Lane 1: 10398G and 10400T; Lane 2: 10398A and10400C.
Figure 3
Figure 3
Polymerase chain reaction-restriction fragment length polymorphism analysis of mitochondrial DNA single nucleotide polymorphism A663G, C5178A, A13263G, A4833G, C12705T, T6392C, and 8280–8290 = A[delCCCCCTCTA] G. (a) Lane M: D2000 marker; Lane 1: 663G; Lane 2: 663A; Lane 3: 5178A; Lane 4: 5178C; Lane 5: 13263G; Lane 6: 13263A; Lane 7: 4833G; Lane 8: 4833A; (b) Lane M: D2000 marker; Lane 1: 12705C; Lane 2: 12705T; (c) Lane M: D2000 marker; Lane 1: 6392C; Lane 2: 6392T; (d) Lane M: Marker-20-bp Ladder; Lane 1: 9-bp Del (+); Lane 2: 9-bp Del (−).
Figure 4
Figure 4
Direct sequencing of the mitochondrial DNA fragments to confirm the alleles of each single nucleotide polymorphism. *Forward sequencing for all of the polymerase chain reaction-amplified fragments except the one encompassing C12705T which was detected by reverse sequencing.

References

    1. Zhang ZX, Roman GC, Hong Z, Wu CB, Qu QM, Huang JB, et al. Parkinson's disease in China: Prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365:595–7. - PubMed
    1. Thomas B, Beal MF. Parkinson's disease. Hum Mol Genet. 2007;16 Spec No 2:R183–94. - PubMed
    1. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE. MPTP, MPP+ and mitochondrial function. Life Sci. 1987;40:721–9. - PubMed
    1. Parker WD, Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol. 1989;26:719–23. - PubMed
    1. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1989;1:1269. - PubMed

Substances